Continue shopping Go to cart

UnscheduledTransfer Pricing: Pharmaceutical and Life Sciences Industry Masterclass

This advanced-level, interactive masterclass will be a joint collaboration with Baker McKenzie. It is designed for tax professionals who are active in the pharmaceutical and life sciences sector, and will give participants more in-depth understanding of the implications of BEPS in their day-to-day practice. Participants will receive a roadmap for the changes that each of the BEPS reports on transfer pricing brings and how these reports are interrelated. 
Please note: This course is not currently scheduled. The price, program and instructors are detailed as per the previous course for information purposes only and may be subject to change.
Tax Courses
Amsterdam - The Netherlands
Course code:
Client offer:
20% discount for IBFD Membership clients and 10% discount for Global Tax Explorer (Plus) clients.
Early Bird Discount: a 30% discount will be automatically applied for registrations received 60 days or more before the commencement of the course (cannot be used in conjunction with other discounts).
Transfer Pricing: Pharmaceutical and Life Sciences Industry Masterclass

Overview and learning objectives
Digitalization has changed and will continue to change business models. This will impact the global value chains of multinational enterprises. At the same time, pharmaceutical companies are growing through clinical partnerships and partnerships with tech giants, start-ups, academia and non-profits. They are also teaming up with other companies. Simultaneously, the OECD has implemented the recommendations resulting from the OECD BEPS Action Plan, and the European Union and United Nations have followed suit. In addition, countries have implemented unilateral rules. Furthermore, the US tax reform and the Brexit create incentives and disincentives for the life sciences sector and impact future investments. Like with other multinationals, all of the aforementioned developments have a potential impact on companies in the pharmaceutical and life sciences sector. However, specific actions may have a larger impact on pharmaceutical companies than companies active in other sectors.

This advanced-level, interactive masterclass consists of case studies and sharing best practices. It is designed for participants who are active in the pharmaceutical and life sciences sector, and who already have knowledge of transfer pricing and want to gain more in-depth understanding of the implications of BEPS in their day-to-day practice. Participants will receive a roadmap for the changes that each of the BEPS reports on transfer pricing brings and how these reports are interrelated

Field of study

Who should attend?
The course is suitable for transfer pricing advisers, lawyers, accountants and in-house transfer pricing managers active in the pharmaceutical and life sciences sector. The course will enable participants who have a good knowledge of transfer pricing principles to gain an in-depth understanding of transfer pricing issues and to learn how to manage them.

Course level and prerequisites
This is an advanced-level course. Participants taking this course will be expected to have a good understanding of transfer pricing principles.

Pre-course preparation
In order to participate in this particular course, no advance preparation is necessary. Prior to the course, participants will receive all course material in a digital format.

Interactive course - "Group Live" 
To safeguard the interactive nature of the course, including group discussions and case studies, a maximum of 32 participants will be accepted. Early registration is therefore recommended.

We invite you to send us in advance any technical, content-related questions you may have. During the course we will try to address your specific questions, but please note that this will depend on the amount of time available, the relevance of the questions and the order in which the questions are received.

Should you have a question, please send it to

Disclaimer: The information provided during the course has been prepared solely for the instruction of course participants. This information is not intended to constitute advice on any particular matter

Continuing Professional Education
Recommended NASBA CPE points for this course: 12.5 (in accordance with the standards of the National Registry of CPE points, CPE credits are granted based on a 50-minute hour). Read more information on CPE points and accreditation for IBFD International Tax Courses.

Course fee and registration details
The course fee covers participation in the course, all course materials, lunch, coffee/tea and refreshments. The costs of accommodation and transport are not covered. If you have any other questions regarding attendance of the course, travel arrangements, payments and cancellations, please consult our FAQ.

  • Developments and the future of life science: where are we going?
  • The broader set of stakeholders and the regulatory environment: how regulatory aspects influence business models
  • Workshop: risk analysis, typical supply chain and operating models
  • Value chain analysis in the industry – evolutionary analysis of the operating models: tax considerations 
  • Workshop: R&D activities and manufacturing, IP generation and ownership models 
  • Workshop: marketing, merchandising, sales and distribution
  • Workshop: designing a transfer pricing system – transactional analysis and methods
  • Workshop: designing a transfer pricing system – current challenges


  • Anuschka Bakker
    Anuschka Bakker is the Manager of the Transfer Pricing and Specialist Knowledge Group of IBFD in Amsterdam. In addition, she acts as the Cluster Manager for the transfer pricing courses offered by...
  • Antonio Russo is Partner (Economist) with Baker & McKenzie and heads the Amsterdam Transfer Pricing Team, which has been awarded the International Tax Review Award for The Netherlands Transfer...
  • Andre Dekker works as a transfer pricing economist with the Baker & McKenzie’s Amsterdam Transfer Pricing team. His main area of focus is intercompany finance transactions and valuation...
  • Jan Willem Gerritsen
    Jan Willem Gerritsen is a tax partner in the Amsterdam office of BakerMcKenzie. With over 25 years of experience his focus is on rendering tax advice to multinationals, particularly in relation to...
  • Julie Yeni
    Julie Yeni is a Partner at the Paris office of Baker McKenzie, where she heads the Pharmaceutical and Healthcare department. Her practice encompasses both advisory and litigation matters. She...
  • Frank Pfluger
    Frank Pflüger is a partner at Baker McKenzie Germany, where he advises healthcare companies on a broad range of industry-specific topics, including clinical research (clinical trial agreements...
  • Els Janssens is a Senior Associate at Baker & McKenzie Habib Al Mulla in Abu Dhabi, where she advises multinational medical device and pharmaceutical clients and investors on healthcare...
    Önder Albayrak is Deputy Head of Global Transfer Pricing & Tax Lead Benelux at Sanofi, a top health care company present in more than 100 countries. He has 17 years of experience in...
  • Montserrat Llopart is a Managing Partner at Baker McKenzie. She has extensive experience in pharmaceutical and health law, as well as in competition law, contract law, licensing and acquisitions...